Metraipolis › archive › dc_2f0926795367
Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study — Europe PMC PMID:40966463
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40966463
- DOI
- 10.1002/clc.70192
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:55:54.356Z
- SHA-256 of the archived text
343c0a470db44623cc5759bc92df6e181a7f6ba29e6176c50db11b7d6231187c- Stable URL of this page
https://metraipolis.com/documento/dc_2f0926795367
How to cite
Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study — Europe PMC PMID:40966463 — Europe PMC (en), https://europepmc.org/article/MED/40966463 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f0926795367 (Metraipolis archive dc_2f0926795367, sha256 343c0a470db44623cc5759bc92df6e181a7f6ba29e6176c50db11b7d6231187c)
BibTeX
@misc{dc2f0926795367,
title = {Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1-Year Comparative Study — Europe PMC PMID:40966463},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40966463},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f0926795367; sha256 343c0a470db44623cc5759bc92df6e181a7f6ba29e6176c50db11b7d6231187c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40966463. Agents can read the archived copy with the MCP tool read_document.